Extendicare Inc. (EXE) reported its third-quarter earnings for 2025, surpassing market expectations with an earnings per share (EPS) of CAD 0.281, compared to the forecasted CAD 0.2113. This 32.99% ...

4,772,798 reviews on ConsumerAffairs are verified. We require contact information to ensure our reviewers are real. We use intelligent software that helps us maintain the integrity of reviews. Our ...

Earnings call Extendicare's Q3 2025 results showed a 22.6% revenue increase and 40.6% adjusted EBITDA growth, driven by 13% organic home healthcare volume growth and contributions from recent ...